Home/ monde MONDEUnited States: FDA Approves Sanofi’s Infilbray for MG3The U.S. drug agency approved Infilbray, a Sanofi treatment for type 3 myasthenia gravis.Published 1h·1 sourceNotable Lire en françaisListen≈ 9sSpeed0.8×1×1.2×1.5×🔗Click the link to read an article on the topic:Boursorama↗🧭Explore this topicÉtats-UnisFDASanofi#États-Unis#FDA#Sanofi#médicament#myasthenie grave#santéWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→États-Unis · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on November 19, 2026← Back to home